Scientists Slam Chinese CRISPR Babies Research After Manuscript Released

Chinese biophysicist He Jiankui had created the twins Lula and Nana in late 2018 using CRISPR.

Advertisement
By Agence France-Presse | Updated: 4 December 2019 10:26 IST
Highlights
  • Gene-editing was performed on Chinese twins last year
  • It was meant to immunise them against HIV
  • It may have failed in its purpose and created unintended mutations

Chinese scientist He Jiankui in a summit on Human Genome Editing in November 2018

Photo Credit: Anthony Wallace/ AFP

The gene-editing performed on Chinese twins last year meant to immunise them against HIV may have failed in its purpose and created unintended mutations, scientists said Tuesday after the original research was made public for the first time. Excerpts from the manuscript were released by the MIT Technology Review for the purpose of showing how Chinese biophysicist He Jiankui ignored ethical and scientific norms in creating the twins Lula and Nana, whose birth in late 2018 sent shockwaves through the scientific world.

He made expansive claims of a medical breakthrough that could "control the HIV epidemic," but it was not clear whether it had even been successful in its intended purpose -- immunizing the babies against the virus -- because the team did not, in fact, reproduce the gene mutation that confers this resistance.

Advertisement

A small percentage of people are born with immunity because of a mutation in a gene called CCR5 and it was this gene that He had claimed he had targeted using a powerful editing tool known as CRISPR which has revolutionized the field since bursting on the scene in 2012.

Fyodor Urnov, a genome-editing scientist at the University of California, Berkeley told the MIT Technology Review: "The claim they have reproduced the prevalent CCR5 variant is a blatant misrepresentation of the actual data and can only be described by one term: a deliberate falsehood.

Advertisement

"The study shows that the research team instead failed to reproduce the prevalent CCR5 variant."

While the team targeted the right gene, they did not replicate the "Delta 32" variation required, instead creating novel edits whose effects aren't clear.

Advertisement

Moreover, CRISPR remains an imperfect tool because it can lead to unwanted or "off-target" edits, making its use in humans hugely controversial.

Here, the researchers claimed they had searched for such effects in the early-stage embryos and found just one -- but this glossed over the fact that it would be impossible to carry out a comprehensive search without inspecting each of the embryo's cells and thus destroying it.

Advertisement

Further ethical concerns included that the parents of the babies might have wanted to take part for the wrong reasons.

The father was HIV positive, which carries a significant social stigma in China and makes it almost impossible to have access to fertility treatment, even though a well-established technique known as "sperm washing" prevents the infection from being passed on to unborn children.

Their lack of access to any kind of fertility treatment may have motivated them to take part in the experiment despite the huge risks to their children, Jeanne O'Brien, a reproductive endocrinologist at Shady Grove Fertility told the MIT Technology Review.

The authors also appeared to have taken steps to make it hard to find the family, like leaving the names of the fertility doctors off the paper, and including a false date of birth (Hu claimed November 2018 while multiple reports have indicated it was in fact October 2018).

He attempted to shop his manuscript around to prestigious journals including Nature and JAMA, but it remains unpublished.

 

Get your daily dose of tech news, reviews, and insights, in under 80 characters on Gadgets 360 Turbo. Connect with fellow tech lovers on our Forum. Follow us on X, Facebook, WhatsApp, Threads and Google News for instant updates. Catch all the action on our YouTube channel.

Further reading: CRISPR, Gene-editing
Advertisement

Related Stories

Popular Mobile Brands
  1. Flipkart Big Billion Days Sale 2026 Date, Offers Leaked
  2. Oppo K14 Lite Set to Launch on This Date
  3. Xiaomi 18 Global Variant Reportedly Gets NCC Certification Ahead of Launch
  4. Redmi 17 5G Goes on Sale in India With These Features
  5. Mivi One 5G Colour Options, More Details Confirmed Ahead of Launch
  6. Moto Buds 2 Fusion Set to Launch in India on This Date
  7. Sony Xperia 1 IX Tipped to Get a Bigger Camera Sensor, Redesigned Module
  8. This Snapdragon Chipset Will Power the Redmi Note 17 Pro Series in India
  9. Refurbished Samsung Galaxy S26, S26 Ultra Now Available in India
  1. Redmi Note 17 Pro, Note 17 Pro Max Chipsets, IP Ratings Revealed Ahead of India Launch
  2. Garmin Cirqa Smart Band Pro Reportedly in Development With Two Buttons, Audio Feedback: Report
  3. Hideo Kojima's Espionage Game Physint Changes Hands From PlayStation to Xbox After Sony Backs Out of Project
  4. Mivi One 5G Colour Options and More Details Revealed Days Before India Launch
  5. Samsung Reportedly Developing Display-Equipped AI Glasses, Launch Slated for 2028
  6. Sony Xperia 1 IX Tipped to Get a Bigger Primary Camera Sensor, Redesigned Module
  7. Oppo K14 Lite India Launch Date Announced; Teased to Feature 7,000mAh Battery
  8. Samsung Ends Support for Galaxy Watch 4 and Galaxy Watch 4 Classic After Five Years
  9. iPhone 18 Pro, iPhone 18 Pro Max Feature Notably Larger Batteries Than Their Predecessors, Reveals Regulatory Filing
  10. Vivo X Fold 6 Global Variant Pops Up on Geekbench With MediaTek Dimensity 9500 Chipset
Download Our Apps
Available in Hindi
© Copyright Red Pixels Ventures Limited 2026. All rights reserved.